Non-executive director Guo Huaqing reduced his holdings of Keji Pharmaceutical (02171) 10,000 shares at a price of HK$17.7 per share

The Zhitong Finance App learned that according to the latest data from the Hong Kong Stock Exchange, on December 8, non-executive director Guo Huaqing reduced his holdings of Keji Pharmaceutical (02171) by 10,000 shares, at a price of HK$17.7 per share, for a total amount of HK$177,000. After the holdings were reduced, the latest number of shares held was approximately 218 million shares, with a shareholding ratio of 37.75%.